Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued research reports about the stock. Craig Hallum cut their price objective on shares of Alimera Sciences from $18.00 to […]
StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts also recently weighed in on the stock. Craig Hallum reduced their target price on shares of Alimera Sciences […]
Analysts at StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report issued on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the stock. HC Wainwright restated a “buy” rating and issued a […]
A number of research firms have changed their ratings and price targets for Alimera Sciences (NASDAQ: ALIM): 4/14/2023 – Alimera Sciences is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 4/6/2023 – Alimera Sciences is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. […]
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently commented on ALIM. HC Wainwright reiterated a buy rating and issued a $9.00 target price on […]